ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,940, issued on Sept. 22, was assigned to Sanford Burnham Prebys Medical Discovery Institute (La Jolla, Calif.) and Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"Dopamine receptor d1 agonists and methods of use" was invented by Brad Savall (San Diego), Andrew J. Haak (Rochester, Minn.) and Daniel J. Tschumperlin (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are small molecule agonists of dopamine receptor D1 that inhibit YAP/TAZ, compositions, and methods of using these compounds and compositions. The methods of using such compounds in the treatment of conditions, diseases, or disorders a...